Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Vernerey

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
JAMA|February 17, 2012
Main air pollutants and myocardial infarction: a systematic review and meta-analysisHazrije Mustafic, Patricia Jabre, Christophe Caussin, et al.
Circulation Research|June 10, 2015
Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating AntibodiesAlexandre Loupy, Dewi Vernerey, Denis Viglietti, et al.
Transplantation|September 16, 2014
Kidney allograft fibrosis after transplantation from uncontrolled circulatory death donorsDenis Viglietti, Imad Abboud, Gary Hill, et al.
Experimental Hematology & Oncology|February 28, 2018
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignanciesJulien Magne, Alizée Jenvrin, Adrien Chauchet, et al.
Health and Quality of Life Outcomes|February 6, 2019
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocolGuillaume Mouillet, Joëlle Fritzsch, Sophie Paget-Bailly, et al.
Journal of the American Society of Nephrology : JASN|August 6, 2016
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft LossDenis Viglietti, Alexandre Loupy, Dewi Vernerey, et al.
Journal of the American Society of Nephrology : JASN|August 22, 2015
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated InjuryCarmen Lefaucheur, Denis Viglietti, Carol Bentlejewski, et al.
Cancers|August 27, 2021
HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort StudyAntoine Baumann, Julie Henriques, Zohair Selmani, et al.
Journal of the National Cancer Institute|May 17, 2020
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial OriginAziz Zaanan, Julie Henriques, Romain Cohen, et al.
Trials|April 14, 2018
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trialGuillaume Mouillet, Marie-Justine Paillard, Tristan Maurina, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
JAMA|February 17, 2012
Main air pollutants and myocardial infarction: a systematic review and meta-analysisHazrije Mustafic, Patricia Jabre, Christophe Caussin, et al.
Circulation Research|June 10, 2015
Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating AntibodiesAlexandre Loupy, Dewi Vernerey, Denis Viglietti, et al.
Transplantation|September 16, 2014
Kidney allograft fibrosis after transplantation from uncontrolled circulatory death donorsDenis Viglietti, Imad Abboud, Gary Hill, et al.
Experimental Hematology & Oncology|February 28, 2018
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignanciesJulien Magne, Alizée Jenvrin, Adrien Chauchet, et al.
Health and Quality of Life Outcomes|February 6, 2019
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocolGuillaume Mouillet, Joëlle Fritzsch, Sophie Paget-Bailly, et al.
Journal of the American Society of Nephrology : JASN|August 6, 2016
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft LossDenis Viglietti, Alexandre Loupy, Dewi Vernerey, et al.
Journal of the American Society of Nephrology : JASN|August 22, 2015
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated InjuryCarmen Lefaucheur, Denis Viglietti, Carol Bentlejewski, et al.
Cancers|August 27, 2021
HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort StudyAntoine Baumann, Julie Henriques, Zohair Selmani, et al.
Journal of the National Cancer Institute|May 17, 2020
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial OriginAziz Zaanan, Julie Henriques, Romain Cohen, et al.
Trials|April 14, 2018
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trialGuillaume Mouillet, Marie-Justine Paillard, Tristan Maurina, et al.
Pageof 16